Great Point Partners LLC
- SEC CIK
- 0001281446
- Latest filing
- Aug 14, 2026
ABOS holding history
Acumen Pharmaceuticals, Inc. in every 13F filed by Great Point Partners LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ABOS overviewAll 13F holders of ABOSFull Q2 2026 holdings
- Shares (Q4 2023)
- 0
- Sold out in Q4 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2023 | 0 | $0 | 0.0% | −1,074,101−100.0% | Sold out | Holders |
| Q3 2023 | 1,074,101 | $4.46M | 0.8% | +22,834+2.2% | Added | Holders |
| Q2 2023 | 1,051,267 | $5.06M | 1.0% | 00.0% | Unchanged | Holders |
| Q1 2023 | 1,051,267 | $4.27M | 0.8% | −65,314−5.8% | Reduced | Holders |
| Q4 2022 | 1,116,581 | $6.03M | 1.2% | −83,419−7.0% | Reduced | Holders |
| Q3 2022 | 1,200,000 | $12.0M | 2.9% | −315,000−20.8% | Reduced | Holders |
| Q2 2022 | 1,515,000 | $7.12M | 1.8% | +586,718+63.2% | Added | Holders |
| Q1 2022 | 928,282 | $3.63M | 0.9% | +928,282 | New | Holders |